Introduction
============

As the preferred treatment strategy, the use of percutaneous coronary intervention (PCI) for patients with acute ST-segment elevation myocardial infarction (STEMI) is increasing.[@b1-jthc-8-146]--[@b3-jthc-8-146] Based on many studies, including a recent analysis from the GRACE (Global Registry of Acute Coronary Events), primary PCI has to be considered as the standard of care in many patients with STEMI.[@b4-jthc-8-146] Nevertheless, there are some limitations regarding primary PCI, which have rendered it an undesirable therapy for many operators and even for many PCI-capable centers. Despite high success rates in terms of epicardial artery patency, a large number of patients experience insufficient myocardial reperfusion mainly at the level of microvascular circulation. Angiographically, failure of reperfusion can be assessed using thrombolysis in myocardial infarction (TIMI) flow grade, TIMI frame count (TFC), and myocardial blush score. Moreover, reperfusion failure is associated with a poor prognosis and has been shown to be an independent predictor of death, MI, and impaired left ventricular function.[@b5-jthc-8-146]--[@b7-jthc-8-146] In clinical practice, ST-segment resolution is deemed a good indicator for the evaluation of reperfusion failure. Several studies have reported a relationship between different degrees of ST-segment resolution and clinical outcomes.[@b8-jthc-8-146]--[@b10-jthc-8-146] A large number of pathophysiological processes, usually in combination, are thought to be responsible for suboptimal myocardial reperfusion during primary PCI. Distal embolization of atherosclerotic debris, thrombus formation, and endothelial dysfunction of the distal arteriolar and capillary bed - including endothelial desquamation and microvascular spasm - are of possible causes.[@b11-jthc-8-146] Many preventive approaches have been tailored to improve myocardial perfusion in this setting. Several, but not all, have shown promising results in patients with STEMI. Patients who seem high risk for the occurrence of reperfusion failure might benefit from a more aggressive approach - including prompt transfer to the catheterization unit, use of new potent oral and parenteral antiplatelet drugs, thrombectomy devices, distal embolic protection, and - if possible - pre- and post-conditioning strategies. It is extremely difficult to completely treat reperfusion failure once it has occurred; therefore, recognition and adjustment of the related factors might decrease the prevalence or at least the severity of this phenomenon.

This retrospective study sough to analyze the rate of myocardial reperfusion following primary PCI and related clinical and angiographic factors associated with suboptimal myocardial reperfusion with a view to contributing to better treatment decisions in certain subgroups of STEMI patients.

Methods
=======

One-hundred fifty-five patients, who presented with acute STEMI to the Emergency Department between 2007 and 2009, were selected. The inclusion criteria were comprised of patients candidated for primary PCI with ST-segment elevation of more than 1 mm in two contiguous leads or 2-mm ST depression in V1 to V4 (true posterior MI)[@b12-jthc-8-146] and one of the following: 1) typical anginal pain and 2) elevated cardiac enzymes (CK-MB, troponin).

Patients with electrocardiographic (ECG) evidence of bundle branch or fascicular block and paced rhythm or those with initial cardiogenic shock were excluded. A guided medical history was taken, physical examination was performed, essential drugs were administered, and transthoracic echocardiography was conducted in all the patients. If eligible, the patients were transferred promptly to the Catheterization Unit, where they underwent coronary angiography. PCI was only done on the culprit artery, which was defined by the operator. The choice of opting for medications or thrombectomy devices was left at the discretion of the attending physician. Procedural success was defined as angiographic success without the occurrence of complications (death, MI, or bypass graft surgery) within 30 days of the procedure.[@b13-jthc-8-146] A 12-lead ECG was obtained 180 minutes after the procedure, and the clinical status of the patients was recorded. The percentage of ST-segment resolution in the leads with maximal initial ST-segment elevation was calculated. Based on the percentage of post-PCI ST-segment resolution, the patients were divided into three distinctive groups:[@b14-jthc-8-146]--[@b17-jthc-8-146] 1) patients with ST-segment resolution greater than 70% from baseline (complete); 2) patients with ST-segment resolution equal to or between 30 and 70% (partial); and 3) patients with less than 30% ST-segment resolution (failed).

The data are described as mean ± standard deviation for the interval and count (%) for the categorical variables. Median (inter-quartile range \[IQR\]) was used for the interval, non-normally distributed variables. Fitness of interval data to normal distribution was assessed using the one-sample Kolmogorov-Smirnov test. Subgroup analysis was performed via the chi square, Mann Whitney U, and Kruskal Wallis tests. A p value smaller than 0.05 was considered statistically significant. SPSS 15 for Windows (SPSS Inc. Chicago, Illinois) was employed for the statistical analyses. Multivariable analysis was performed using an ordinal logistic regression model to determine the adjusted associations between ST-segment resolution and other determinants. STATA SE11 for Windows (STATA Corp. Texas, USA) was applied for statistical modeling.

Results
=======

One-hundred fifty-five patients (124 men; mean age = 56.6 ± 11.03 years, range = 31--85 years) were recruited in the present study. Dyslipidemia (43.9%) and smoking (40.6%) were the most common risk factors, and a relatively large number of the study patients (25%) suffered from diabetes mellitus. The demographic characteristics of the study population are depicted in [Table 1](#t1-jthc-8-146){ref-type="table"}.

With respect to the culprit artery, the left anterior descending artery was involved in 59.4% of the cases, followed by the right coronary artery (31.6%) and the left circumflex artery (4.5%). The angiographic characteristics of the study population are outlined in [Table 2](#t2-jthc-8-146){ref-type="table"}. Procedural success was 97.1%, and the majority of the patients (98.7%) experienced complete relief of chest pain. A great number of the patients achieved TIMI-3 flow (88.4%) after the procedure, and slow-flow and no-reflow phenomena were seen in 10.3% and 1.3%, respectively. Despite the fact that the majority of the study patients achieved TIMI-3 flow (88.4%) and the fact that the patients with TIMI flow-3 accounted for 91% of the patients with complete ST resolution, TIMI-3 flow was also equally distributed between the patients with partial resolution and those with no resolution (p value = 0.55). Complete ST-segment resolution (\> 70%) occurred in 43.2% and 63.2%, when the value of 50% was considered. Meanwhile, 23.2% of the patients experienced less than 30% ST-segment resolution. There was no association between age or sex and the magnitude of ST-segment resolution (p value = 0.78 and 0.11, respectively). When considered separately, none of the cardiac risk factors was associated with ST change after revascularization ([Table 3](#t3-jthc-8-146){ref-type="table"}). When the analysis was conducted with the ST-segment resolution of 50%, significant relationships were observed with smoking (p value = 0.02), obesity (p value = 0.02), and positive family history (p value = 0.03). The presence of more than three cardiac risk factors was allied to failed reperfusion (p value = 0.05). A history of previous MI or revascularization, including PCI or surgical bypass graft, was not a good determinant (p value = 0.1).

Time from symptom onset to initial puncture of the femoral artery in the catheterization laboratory was significantly related to the magnitude of ST-segment resolution (p value = 0.001). The median (IQR) of presentation time (hours) was 3 (1.5 -- 5.5) in the patients with complete resolution, 5 (2 -- 8) in those with partial resolution, and 5.5 (2 -- 10) in the ones with no resolution. There was also a statistically significant association between initial ejection fraction, obtained at the time of presentation in the Emergency Department, and myocardial reperfusion, as is shown in [Table 3](#t3-jthc-8-146){ref-type="table"}. The analysis of the culprit artery associations threw up an interesting finding: whenever the right coronary artery was treated as the culprit artery, more degrees of ST-segment resolution were achieved, while the involvement of the left anterior descending artery was associated with poor myocardial reperfusion in spite of a successful procedure (p value = 0.001). Similarly, when the anterior wall of the left ventricle was not involved, higher levels of reperfusion were attained. Neither the involvement of the septal or lateral wall, nor the right ventricle complicating inferior MI was significantly associated with the degree of ST-segment resolution. Thrombectomy catheters were used in 104 (64.5%) patients, but they were not correlated with better ST resolution in this study (p value = 0.4). In addition, GpIIb/IIIa inhibitors did not affect electrocardiographic reperfusion.

Multivariate Analysis
=====================

Our multivariate analysis using an ordinal logistic regression model revealed a strong association between failed reperfusion and the variables of time of symptom onset (OR \[95% CI\]: 0.45 \[0.2 to 0.98\]; p value = 0.044), ejection fraction (OR \[95% CI\]: 0.37 \[0.26 to 0.91\]; p value = 0.05), and male gender (OR \[95% CI\]: 0.34 \[0.11 to 1.08\]; p value = 0.068) ([Table 4](#t4-jthc-8-146){ref-type="table"}).

Discussion
==========

Approximately, one-third of acute coronary syndrome patients experience STEMI.[@b18-jthc-8-146] Rapid and complete restoration of the coronary blood flow using thrombolytics or transcatheter interventions is the mainstay of treatment.[@b19-jthc-8-146] Currently, primary PCI is the treatment of choice in many patients with acute MI inasmuch as not only can it confer more complete and protected reperfusion but also it can result in small infarct sizes and reduced mortality rates by comparison with fibrinolytic therapy.[@b20-jthc-8-146] Despite increased knowledge about the pathophysiological stream of STEMI and huge technological progress in the field of coronary interventions, there are still a small but significant number of patients who experience suboptimal results after primary PCI. If we regard STEMI as a risky and costly health problem even with maximal care, the impact of unsuccessful treatment would be clear. The most important cause of suboptimal results is reperfusion failure, which can lead to increased short- and long-term mortality. As was mentioned before, there are several measures to evaluate reperfusion failure post intervention. Of those, slow/no-reflow phenomena or prolonged TFC and impaired myocardial blush score have higher levels of association with insufficient epicardial flow, not merely failed reperfusion, at the levels below the large vessels. It seems that the amount of post-procedural ST-segment resolution is a better estimate for this purpose. Indeed, our study showed that TIMI flow might not yield a precise estimate of myocardial reperfusion.

The present study suggests that the status of the initial risk profile of patients might denote a rough estimate of the success rate of reperfusion as measured by ST-segment resolution. Even if the presence of every one of the usual cardiac risk factors is not strongly associated with poorer results, the accumulation of several of them in a patient could predict a lower chance for complete reperfusion. Time is the key element itself, and can potentiate the effects of the other factors. Although some of the previous studies have suggested that the association between time to treatment and final infarct size is weak if patients are treated with primary PCI,[@b21-jthc-8-146] our study demonstrated a linear relationship between time delay and the magnitude of reperfusion failure, which can be translated into the clinical outcome. This re-emphasizes the importance of the establishment of a general approach in health care systems to achieve lower ischemic times in patients with acute STEMI. We observed that the involvement of the right coronary artery, as the culprit lesion in acute MI, was strongly associated with higher degrees of ST-segment resolution; this can be due to the interesting ability of the right ventricle in handling the ischemic process or smaller sizes of infarcts in many patients with inferior MI. Despite our data, uncertainty persists because observational data show that some patients with inferior MI are more prone to the development of early cardiogenic shock and have increased mortality possibly due to more extensive coronary artery disease and the involvement of the right ventricle.[@b22-jthc-8-146]--[@b24-jthc-8-146] Notably, patients with the acute occlusion of the left anterior descending artery are those who have the lowest levels of myocardial reperfusion and might benefit from a more aggressive therapy, including the routine use of thrombectomy devices and glycoprotein IIb/IIIa receptor antagonists as well as the possible adoption of a pre-PCI fibrinolytic therapy in case of prolonged transfer times.

Conclusion
==========

Considering the initial risk profile of patients with acute STEMI, including time of symptom onset and ejection fraction, as well as the accumulation of cardiac risk factors in a given patient, it is possible to predict failed myocardial reperfusion with a view to designing a more aggressive therapeutic strategy.
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###### 

Demographic characteristics of the study patients

  --------------------------------------------------------- ----------------------
  Age (y)                                                   
    Mean±SD                                                 56.6±11.03 years
    Range                                                   31 to 85
  Sex (M/F)                                                 124 (80%) / 31 (20%)
  Risk factors                                              
    Smoking                                                 63 (40.6%)
    Hypertension                                            58 (37.4%)
    Dyslipidemia                                            68 (43.9%)
    Diabetes                                                39 (25.2%)
    Family history                                          23 (10.9%)
  Previous MI                                               27 (17.4%)
  Previous PCI                                              16 (10.3%)
  Previous surgical bypass graft                            5 (3.2%)
  Onset of symptoms                                         
    \< 6 hours                                              94 (60.6%)
    ≥ 6 hours                                               61 (39.45)
  BMI[^\*^](#tfn1-jthc-8-146){ref-type="table-fn"}          26 (24--29)
  Initial EF[^\*^](#tfn1-jthc-8-146){ref-type="table-fn"}   40% (35%--45%)
  --------------------------------------------------------- ----------------------

Data are presented as median (IQR)

MI, Myocardial infarction; PCI, Percutaneous coronary intervention; BMI, Body mass index; EF, Ejection fraction

###### 

Angiographic and procedural characteristics of the study patients

  -------------------- -------------
  Severity of CAD      
    LM                 1 (0.6%)
    3VD                45 (29%)
    2VD                42 (27%)
    SVD                67 (43%)
  Culprit artery       
    LAD                92 (59.4%)
    LCX                7 (4.5%)
    RCA                49 (31.6%)
    LM                 1 (4.5%)
    Others             6 (0.6%)
  Post-PCI TIMI flow   
    0, 1               2 (1.3%)
    2                  16 (10.3%)
    3                  137 (88.4%)
  -------------------- -------------

CAD, Coronary artery disease; LM, Left main; 3VD, Three-vessel disease; 2VD, Two-vessel disease; SVD, Single-vessel disease; LAD, Left anterior descending artery; LCX, Left circumflex artery; RCA, Right coronary artery; TIMI, Thrombolysis in myocardial infarction

###### 

Relation between the variables and amount of ST--segment resolution in the study patients

  Evaluated factors                                                     ST-resolution \< 30% (n=36)   ST-resolution 30--70% (n=52)   ST-resolution \> 70% (n=67)   P value
  --------------------------------------------------------------------- ----------------------------- ------------------------------ ----------------------------- ---------
  Age (y)                                                                                                                                                          0.780
    \< 50                                                               38.9%                         17.3%                          28.4%                         
    ≥ 50                                                                61.1%                         82.7%                          71.6%                         
  Sex                                                                                                                                                              0.12
    Male                                                                33 (91.7%)                    41(78.8%)                      50 (74.6%)                    
    Female                                                              3 (8.3%)                      11 (21.2%)                     17 (25.4%)                    
  Smoking                                                               18 (50.0%)                    20 (38.5%)                     25 (37.3%)                    0.42
  Diabetes                                                              9 (25.0%)                     13 (25.0%)                     17 (25.4%)                    0.990
  Hypertension                                                          16 (44.4%)                    22 (42.3%)                     20 (29.9%)                    0.230
  Dyslipidemia                                                          14 (38.9%)                    23 (44.2%)                     31 (46.3%)                    0.770
  Obesity                                                               3 (8.3%)                      6 (11.5%)                      15 (22.3%)                    0.107
  Family history                                                        3 (8.3%)                      7 (13.4%)                      13 (19.4%)                    0.303
  Onset of symptoms (hr)[^\*^](#tfn4-jthc-8-146){ref-type="table-fn"}   5.5 (2.0 -- 10.0)             5 (2.0 -- 8.0)                 3 (1.5 -- 5.5)                0.001
  Initial EF (%)[^\*^](#tfn4-jthc-8-146){ref-type="table-fn"}           35 (30.0 -- 42.5)             40 (30.0 -- 42.5)              45 (40.0 -- 45.0)             0.001
  Previous MI                                                           6 (16.7%)                     8 (15.4%)                      13 (19.4%)                    0.84
  Culprit artery                                                                                                                                                   0.001
    LAD                                                                 28 (77.8%)                    36 (69.2%)                     28 (41.8%)                    
    LCX                                                                 1 (2.8%)                      4 (7.7%)                       7 (10.4%)                     
    RCA                                                                 6 (16.7%)                     11 (21.2%)                     32 (47.8%)                    
  Thrombectomy device                                                   24 (66.6%)                    33 (63.5%)                     47 (70.1%)                    0.74
  GpIIb/IIIa inhibitor                                                  10 (27.8%)                    16 (30.7%)                     20 (29.9%)                    0.955

Data are presented as median (IQR)

EF, Ejection fraction; LAD, Left anterior descending artery; LCX, Left circumflex artery; RCA, Right coronary artery; Glycoprotein IIb/IIIa inhibitor

###### 

Multivariable analysis, providing adjusted associations between ST-segment resolution and the variables in the study patients

                          Odds Ratio   95% Confidence Interval   P value   
  ----------------------- ------------ ------------------------- --------- -------
  Gender                  0.34         0.11                      1.08      0.068
  Smoking                 0.58         0.26                      1.30      0.189
  Family history          1.85         0.63                      5.43      0.265
  Diabetes mellitus       0.91         0.33                      2.50      0.860
  Hypertension            0.53         0.22                      1.26      0.151
  Dyslipidemia            1.09         0.49                      2.43      0.828
  Age                     1.02         0.42                      2.48      0.966
  Obesity                 2.10         0.82                      5.38      0.121
  Myocardial infarction   0.74         0.25                      2.17      0.587
  Onset of symptoms       0.45         0.20                      0.98      0.044
  Ejection fraction       0.37         0.26                      0.91      0.050
